SE9503731D0 - Ny användning av hydrofoba zeoliter och ny produkt innehållande sådana - Google Patents
Ny användning av hydrofoba zeoliter och ny produkt innehållande sådanaInfo
- Publication number
- SE9503731D0 SE9503731D0 SE9503731A SE9503731A SE9503731D0 SE 9503731 D0 SE9503731 D0 SE 9503731D0 SE 9503731 A SE9503731 A SE 9503731A SE 9503731 A SE9503731 A SE 9503731A SE 9503731 D0 SE9503731 D0 SE 9503731D0
- Authority
- SE
- Sweden
- Prior art keywords
- solutions
- pct
- new
- hydrophobic zeolites
- product containing
- Prior art date
Links
- 239000010457 zeolite Substances 0.000 title abstract 3
- 230000002209 hydrophobic effect Effects 0.000 title abstract 2
- 239000000243 solution Substances 0.000 abstract 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000003755 preservative agent Substances 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229910021536 Zeolite Inorganic materials 0.000 abstract 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000012460 protein solution Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
- B01J20/16—Alumino-silicates
- B01J20/18—Synthetic zeolitic molecular sieves
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9503731A SE505274C2 (sv) | 1995-10-24 | 1995-10-24 | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning |
US09/051,752 US5936061A (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
CA002235767A CA2235767A1 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
JP9516525A JPH11514920A (ja) | 1995-10-24 | 1996-10-15 | ポリペプチド溶液から防腐剤を除去するための疎水性ゼオライトの使用、シリンジおよび方法 |
DE69623354T DE69623354T2 (de) | 1995-10-24 | 1996-10-15 | Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung |
AT96935707T ATE222802T1 (de) | 1995-10-24 | 1996-10-15 | Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung |
AU73524/96A AU693047B2 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
EP96935707A EP0956155B1 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
PCT/SE1996/001306 WO1997015391A1 (en) | 1995-10-24 | 1996-10-15 | Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9503731A SE505274C2 (sv) | 1995-10-24 | 1995-10-24 | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9503731D0 true SE9503731D0 (sv) | 1995-10-24 |
SE9503731L SE9503731L (sv) | 1997-04-25 |
SE505274C2 SE505274C2 (sv) | 1997-07-28 |
Family
ID=20399935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9503731A SE505274C2 (sv) | 1995-10-24 | 1995-10-24 | Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning |
Country Status (9)
Country | Link |
---|---|
US (1) | US5936061A (sv) |
EP (1) | EP0956155B1 (sv) |
JP (1) | JPH11514920A (sv) |
AT (1) | ATE222802T1 (sv) |
AU (1) | AU693047B2 (sv) |
CA (1) | CA2235767A1 (sv) |
DE (1) | DE69623354T2 (sv) |
SE (1) | SE505274C2 (sv) |
WO (1) | WO1997015391A1 (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802140D0 (sv) * | 1998-06-16 | 1998-06-16 | Ordio Ab | Zeoliter för adsorption |
SE9804029D0 (sv) * | 1998-12-09 | 1998-12-09 | Ordio Ab | Adsorption av ftalater |
US6589224B2 (en) * | 2001-02-14 | 2003-07-08 | Renal Tech International Llc | Method of introducing fluids into a patient's body |
US20050031708A1 (en) * | 2003-08-06 | 2005-02-10 | Portney Micah S. | Composition comprising a zeolite compound for treatment of diseases |
US20090111751A1 (en) * | 2006-02-24 | 2009-04-30 | Novo Nordisk Health Care Ag | Method of Removing a Non-Metallic Protein Inhibitor From a Liquid Pharmaceutical Preparation |
CA2574746A1 (en) * | 2007-01-22 | 2008-07-22 | Duoject Medical Systems Inc. | Syringe having venting structure and method for mixing two substances in a syringe |
WO2009027478A2 (en) * | 2007-08-29 | 2009-03-05 | Novo Nordisk Health Care Ag | A method of removing preservatives from a liquid pharmaceutical preparation |
US10130288B2 (en) | 2013-03-14 | 2018-11-20 | Cell and Molecular Tissue Engineering, LLC | Coated sensors, and corresponding systems and methods |
US10405961B2 (en) | 2013-03-14 | 2019-09-10 | Cell and Molecular Tissue Engineering, LLC | Coated surgical mesh, and corresponding systems and methods |
EP3179975A4 (en) * | 2014-08-13 | 2018-04-18 | University of Florida Research Foundation, Inc. | Preservative removal from eye drops |
WO2016196516A1 (en) | 2015-06-03 | 2016-12-08 | William Kenneth Ward | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
CN109069740B (zh) * | 2016-04-22 | 2021-10-29 | 伊莱利利公司 | 用于减少胰岛素中的间甲酚浓度的具有包含聚合吸着剂的组件的输注组 |
EP3618890A1 (en) | 2017-05-01 | 2020-03-11 | Becton, Dickinson and Company | Filter for reducing phenolic compounds from insulin and related infusion and injection devices |
MX2019014615A (es) | 2017-06-08 | 2020-02-07 | Amgen Inc | Dispositivo de administracion de farmacos accionado por par de torsion. |
JP7517996B2 (ja) * | 2018-04-27 | 2024-07-17 | ベクトン・ディキンソン・アンド・カンパニー | 送達デバイスおよび吸着剤 |
WO2019236653A1 (en) * | 2018-06-06 | 2019-12-12 | Entopsis Llc | System and method for removing phenolic preservations from insulin formulations |
CN115397374A (zh) | 2019-12-19 | 2022-11-25 | 特清公司 | 从滴眼剂中去除防腐剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4240986A (en) * | 1979-02-23 | 1980-12-23 | Uop Inc. | Process for the separation of ortho-chloronitrobenzene |
EP0021267B1 (en) * | 1979-06-18 | 1982-06-16 | PQ Corporation | Agglomerated zeolite ion exchanger |
SE8902919L (sv) * | 1989-09-05 | 1991-03-05 | Haakan Eriksson | Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer |
SE9201976D0 (sv) * | 1992-06-26 | 1992-06-26 | Tektolit Ab Haakan Eriksson | En metod foer att adsorbera proteiner och peptider till hydrofoba zeoliter |
US5314855A (en) * | 1992-11-09 | 1994-05-24 | Akzo N.V. | Adsorbent compositions and methods of manufacture |
US5585007A (en) * | 1994-12-07 | 1996-12-17 | Plasmaseal Corporation | Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant |
-
1995
- 1995-10-24 SE SE9503731A patent/SE505274C2/sv not_active IP Right Cessation
-
1996
- 1996-10-15 DE DE69623354T patent/DE69623354T2/de not_active Expired - Fee Related
- 1996-10-15 AU AU73524/96A patent/AU693047B2/en not_active Ceased
- 1996-10-15 US US09/051,752 patent/US5936061A/en not_active Expired - Fee Related
- 1996-10-15 JP JP9516525A patent/JPH11514920A/ja not_active Ceased
- 1996-10-15 EP EP96935707A patent/EP0956155B1/en not_active Expired - Lifetime
- 1996-10-15 CA CA002235767A patent/CA2235767A1/en not_active Abandoned
- 1996-10-15 AT AT96935707T patent/ATE222802T1/de not_active IP Right Cessation
- 1996-10-15 WO PCT/SE1996/001306 patent/WO1997015391A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2235767A1 (en) | 1997-05-01 |
DE69623354D1 (de) | 2002-10-02 |
WO1997015391A1 (en) | 1997-05-01 |
JPH11514920A (ja) | 1999-12-21 |
EP0956155B1 (en) | 2002-08-28 |
EP0956155A1 (en) | 1999-11-17 |
DE69623354T2 (de) | 2003-01-09 |
AU7352496A (en) | 1997-05-15 |
US5936061A (en) | 1999-08-10 |
ATE222802T1 (de) | 2002-09-15 |
SE505274C2 (sv) | 1997-07-28 |
AU693047B2 (en) | 1998-06-18 |
SE9503731L (sv) | 1997-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9503731D0 (sv) | Ny användning av hydrofoba zeoliter och ny produkt innehållande sådana | |
CA2115348A1 (en) | Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes | |
AU3909497A (en) | Anti-chlamydial methods and materials | |
BR9714354A (pt) | Oxadiazóis, processos para sua preparação e seu emprego como medicamentos | |
CA2181150A1 (en) | Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof | |
DK1032374T3 (da) | Sphroider, fremgangsmåde og farmaceutiske præparater | |
CA2158058A1 (en) | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof | |
AU1679795A (en) | Anti-fungal methods and materials | |
ATE165976T1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
MXPA02010648A (es) | Formulaciones liquidas. | |
DE69530844D1 (de) | Verfahren und substanzen gegen protozoen | |
NL194612B (nl) | Aromatische, alkenisch onverzadigde retino´den, alsmede dergelijke verbindingen bevattende farmaceutische en cosmetische preparaten. | |
ES2173923T3 (es) | Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente. | |
PT1032391E (pt) | Esferoides contendo tiagabina processo de preparacao e composicoes farmaceuticas | |
FR2708198B1 (fr) | Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea. | |
FR2677248B1 (fr) | Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de brunelle. | |
PT789764E (pt) | Nova familia de inibidores de protease e outras substancias biologicas activas | |
FR2675020B1 (fr) | Produit solide contenant des composants de propolis, preparation et applications. | |
SI0876158T1 (en) | Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms | |
TR199900596T2 (xx) | Otoim�n hastal�klara kar�� maddeler olarak proteinlerin kullan�m�. | |
CA2191406A1 (en) | Process for removing aromatic compounds from product-containing solutions | |
BR9910454A (pt) | Preparações efervescentes | |
FI971427A0 (sv) | Peptider och farmaceutiska kompositioner innehållande dessa | |
AU2242897A (en) | Protein occlusion for delivery of small molecules | |
DK0653939T3 (da) | Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |